Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT04745234
Title Mogamulizumab Q4week Dosing in Participants With R/R CTCL
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Kyowa Kirin, Inc.
Age Groups: senior | adult
Covered Countries USA | ITA | GBR | FRA | ESP

Facility Status City State Zip Country Details
City of Hope National Medical Center Duarte California 91010 United States Details
University of California Irvine Irvine California 92697 United States Details
Stanford Cancer Center Stanford California 94304 United States Details
Tulane University School of Medicine New Orleans Louisiana 70112 United States Details
New York Presbyterian Hospital New York New York 10032 United States Details
University of Pittsburgh School of Medicine Pittsburgh Pennsylvania 15213 United States Details
MD Anderson Cancer Center Houston Texas 77030 United States Details
Hôpital Saint Louis Paris France Details
Azienda Ospedaliera Città della Salute e della Scienza di Torino Turin Italy Details
Hospital del Mar Barcelona Spain Details
Hospital Universitario 12 de Octubre Madrid Spain Details
Hospital Universitario Fundacion Jimenez Diaz Madrid Spain Details
Hospital Universitario De Salamanca Salamanca Spain Details
Queen Elizabeth Hospital Birmingham United Kingdom Details
Guy's and St Thomas' NHS Foundation Trust - Guy's Hospital London United Kingdom Details
The Christie NHS Foundation Trust Manchester United Kingdom Details
*Shaded cells indicate that there was no data available from for the field